Novel heterocyclic compounds as erk inhibitors
作者： Phieng Siliphaivanh , Brendan M. O'boyle , Umar Faruk Mansoor , Jayaram R. Tagat , Sie-Mun Lo
DOI:
关键词:
摘要: The present invention provides a compound of the Formula I:(Formular I should be inserted here) or pharmaceutically acceptable salt, solvate ester thereof, wherein R, R1, R2 and R3 are as defined herein. compounds ERK inhibitors. Also disclosed pharmaceutical compositions comprising above methods treating cancer using same.
lens.org 参考文章(246)
Fried Josef, Acetals and ketals of 16, 17-dihydroxy steroids ,(1960)
James P. Karwowski, Jill E. Hochlowski, Marianna Jackson, Sunil K. Kadam, James B. McAlpine, Dorrigocin antitumor agents ,(1995)
Manoj C. Desai, Terry J. Rosen, Substance p antagonists ,(1990)
George Albers-Schonberg, Preparation of ammonium salt of hypocholesteremic fermentation product ,(1980)
John Hood, Sunil Kumar Kc, Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof ,(2010)
Paul E. Finke, Malcolm MacCoss, Daniel J. Miller, Sander G. Mills, Dennis J. Underwood, Alicyclic compounds as tachykinin receptor antagonists ,(1992)
Serge Grisoni, Michel Tabart, Daniel Achard, Jean-Francois Peyronel, Jean-Luc Malleron, Perhydroisoindole derivatives as antagonists of substance P ,(1993)
Matthew Ronsheim, Gian-Luca Araldi, Indazole derivatives useful as melanin concentrating receptor ligands ,(2007)
Yoshiaki Banyu Pharmaceutical Co. Ltd. Monden, Yoshikazu Banyu Pharmaceutical Co. Ltd. Iwasawa, Toshihiko Banyu Pharmaceutical Co. Ltd. Satoh, Tetsuya Banyu Pharmaceutical Co. Ltd. Aoyama, Sachie Banyu Pharmaceutical Co. Ltd. Arai, Kumiko Banyu Pharmaceutical Co. Ltd. Kawakami, Substituted amide derivatives ,(1997)
William S Allen, Robert H Lenhard, Bernstein Seymour, 16-alpha oxy-belta1, 4-pregnadienes ,(1956)